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Introduction
Coronavirus disease 2019 (COVID-19) has had a pro-
found effect on the availability of surgical resources1.
Vascular services have been severely affected by these
challenges. Some vascular societies have issued guidance
on what operative case mix should be undertaken during
the pandemic2–4. These include adapting service provi-
sion for elective and urgent vascular presentations such
as stroke and aortic aneurysm. However, the exact impact
of the pandemic is still unknown5. The Vascular and
Endovascular Research Network (VERN) is an established
vascular research collaborative6–9 that responded rapidly
to the pandemic by delivering the COVID-19 Vascu-
lar SERvice (COVER) study, an international prospective
mixed-methodology project. The aim of the first part of the
COVER study described here (tier 1) is to document fluc-
tuations in vascular services globally during the first phase
of the pandemic.
Methods
International guidelines on designing and reporting of
surveys were used10. The study protocol is available online
(https://www.medrxiv.org/content/10.1101/2020.05.27
.20114322v1; ISRCTN 80453162).
A remote digital survey was developed by a global team
of vascular healthcare professionals. Questions related
to all aspects of vascular care, including staff availability,
multidisciplinary team input, and personal protective
equipment (PPE) (Appendix S2, supporting information).
Results reported here are for the period 23 March to 3 May
2020, divided into three 2-week periods for comparison.
Duplicate responses were removed.
International/continental comparisons were performed,
where possible, to describe relative change in practice.
A score of 0–3 was allocated to each answer based on per-
ceived relative service reduction by 12 VERN healthcare
professionals (0 represents no change and 3 the most sig-
nificant change) (Appendix S3, supporting information).
Results
Overall, 465 completed survey responses were collected
from 249 different units in 53 countries across six conti-
nents (Table S1, supporting information). Fig. 1 shows all
unit responses together with overall mean service reduc-
tions and worldwide response. The reductions in service
measures for individual countries are shown in Appendix S3
(supporting information).
Carotid surgery
Globally, 17⋅7 per cent of units offered intervention only
to patients with crescendo transient ischaemic attacks, 43⋅5
per cent continued to offer surgery on a case-by-case basis,
and 36⋅4 per cent made no changes to their carotid practice.
Aortic screening programmes
Of those units offering aortic aneurysm screening services,
45⋅8 per cent stopped all screening activities, 18⋅7 per
cent continued a reduced programme, and 7⋅9 per cent
continued screening as usual.
Aortic pathology
Thresholds for abdominal aortic aneurysm (AAA) repair
were raised in the majority of centres; 11⋅7 per cent of vas-
cular units limited surgery to AAA more than 6⋅5 cm in
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Fig. 1 Global overall mean service reductions, worldwide response, and service reduction scores in the UK and the Americas
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Grey circles represent centre responses, indicating more populated data at the start and end of the time period. Global overall mean vascular practice was
already reduced at the start, remaining relatively steady throughout. Compared with this, vascular surgical units in the UK (lockdown date 23 March 2020)
began to implement more significant reductions in services. These measures became steadily more significant until around the time when the pandemic
peaked locally (between 10 and 20 April).
Table 1 Changes to management of lower-limb arterial pathology during the study period and overall
Fortnight 1 Fortnight 2 Fortnight 3 Overall
No change 19⋅7 1⋅9 13⋅9 15⋅4
Increasing endovascular management 19⋅7 17⋅2 17⋅9 18⋅2
Increasing direct to amputation or palliation 19⋅7 19⋅7 25⋅4 23⋅6
Limit revascularization to tissue loss 18⋅9 14⋅7 15⋅6 16⋅3
Limit revascularization to severe rest pain or tissue loss only 19⋅7 26⋅7 24⋅3 23⋅6
Other 2⋅4 3⋅4 2⋅9 2⋅9
Values are percentages.
maximal diameter, 16⋅4 per cent to those above 7 cm, 25⋅1
per cent to symptomatic or ruptured AAA, and 2⋅3 per cent
to AAA suitable for endovascular AAA repair (EVAR) only.
Despite this, 25⋅1 per cent reported no change in practice.
Access to EVAR out of hours was initially available to 8⋅5
per cent of responding units, increasing to 21⋅2 per cent in
the following 4 weeks. Overall, only 14⋅2 per cent of units
maintained a 24/7 EVAR service, 26⋅3 per cent maintained
an ‘in hours’ service, 31⋅5 per cent offered EVAR for urgent
cases only, and 18⋅5 per cent were able to run their service
on an ad hoc basis only. Post-EVAR surveillance contin-
ued as normal in 24⋅6 per cent of units. However, 35⋅2
per cent had reduced availability and 31⋅8 per cent stopped
it completely. The majority of units (56⋅6 per cent) main-
tained their pathways for acute aortic syndromes (type B
aortic dissection, penetrating aortic ulcer, and intramural
haematoma). A small proportion (5⋅9 per cent) moved to
conservative management only, 4⋅5 per cent were offer-
ing early endovascular surgery, and 26⋅6 per cent limited
surgery to ruptures.
Lower limb
Changes to the management of lower-limb pathol-
ogy are shown in Table 1 for each 2-week period.
The majority of units began offering a greater pro-
portion of major amputation or palliation rather than
© 2020 The Authors. British Journal of Surgery published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2020; 107: 1396–1400
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attempting revascularization for chronic limb-threatening
ischaemia, with 60⋅4% of units documenting a move to an
endovascular-first treatment strategy, especially in critical
limbs (rest pain or tissue loss).
Outpatient clinics
Some 27⋅5 per cent of units moved to a triage clinic system,
and 29⋅0 per cent cancelled all planned outpatient clinics.
Use of technology permitted 14⋅9 per cent of units to move
to video or telephone clinics, with 18⋅7 per cent including
subsequent triage for attendance if required. The use of
‘hot’ clinics (reserved for acute/urgent patients) increased
during the pandemic, and 79⋅1 per cent of units reported
using some form of hot clinic to accommodate vascular
patients.
Multidisciplinary team meetings
Overall, 32⋅2 per cent of units that normally partici-
pated in a multidisciplinary team (MDT) continued with
face-to-face meetings; 59⋅5 per cent stopped regular
face-to-face meetings and, of those, 39⋅1 per cent did not
replace them. Overall, 36⋅8 per cent moved to remote
conferencing.
Staff redeployment
Globally, 5⋅5 per cent of senior surgeons were redeployed
to support other specialties, compared with 53⋅5 per cent
of junior vascular surgical staff.
Personal protective equipment
The majority (80⋅5 per cent) of units had PPE guidance in
place. Some 26⋅2 per cent of units did not have access to
adequate PPE at the start, compared with 17⋅5 per cent at
the end of the period.
Discussion
The COVER study is the first international prospective
study of unit-level vascular surgical practice during the
COVID-19 pandemic. Findings from tier 1 suggest radical
changes in practice in a range of services.
One notable change across participating vascular units
is the reduction in AAA screening activity. The benefit of
AAA screening, and the likelihood of finding a new AAA
(less than 1⋅5 per cent)11, must be balanced against the
risk of COVID-19 transmission and allocation of resources.
Given that the majority of units reported higher size
thresholds for AAA intervention, the chances of finding
AAAs large enough to be considered for repair at this time
are even lower. UK National AAA Screening Programme
data suggest that 809 threshold AAAs are identified annu-
ally (2018)12, which implies that there will be a UK backlog
of approximately 130 AAAs relating to this 6-week study
period, with resource implications after the pandemic. This
will be replicated to some degree worldwide.
Another common finding is the reported preference for
endovascular strategies to address aortic and peripheral
arterial disease; this is thought to be based on a drive
to minimize hospital stay and reduce demand on ICU
beds13,14. For EVAR, a paradigm has been created where,
potentially, more EVAR is performed during the pan-
demic, but with a reduction in post-EVAR surveillance.
There are important implications relating to the finan-
cial resources, operating time and staffing that will be
required to catch up with missed scans and scheduled oper-
ations as services begin to resume. Vascular patients will be
competing with the estimated 28 million operations can-
celled or postponed during the peak of the pandemic15. For
lower-limb pathology, the results of an increased endovas-
cular approach on limb-related outcomes will also be
important to follow.
MDT meetings support individual clinician decision-
making by navigating complex decisions through a multi-
faceted approach. COVID guidelines2–4 have provided rec-
ommendations that potentially go against surgeons’ usual
inclinations. Anecdotally, patients who may have received
active treatment before the pandemic were being palli-
ated owing to the perceived high risk of intervention,
especially if they tested positive for COVID-19. Strate-
gies have moved towards endovascular management where
open surgery would have been the surgeon’s usual prefer-
ence. Replacing a face-to-face MDT with virtual meetings
has facilitated ongoing access to MDT support for such
complex decision-making during this challenging period.
Despite the large number of units taking part, correlating
individual country or regional data with dates of lockdown
is challenging. Dates of lockdown were, however, similar
for countries providing the majority of responses (UK,
Germany, USA). All participating units entered lockdown
in March 2020, and were in lockdown when the survey
began. If there are any subsequent COVID-19 ‘waves’ in
areas that are ‘past the peak’16–21, or in locations where
the pandemic peak has yet to occur, these data will support
vascular surgeons in terms of practice and the resources
needed.
© 2020 The Authors. British Journal of Surgery published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2020; 107: 1396–1400
on behalf of BJS Society Ltd.
Impact of the first COVID-19 wave on global vascular services 1399
Acknowledgements
The VERN executive committee formally acknowledges
the support of and collaboration with the following
international groups and networks: Vascular Society of
Great Britain and Ireland (VSGBI), Rouleaux Club (RC),
GLOBALSurg, British Society of Endovascular Ther-
apy (BSET), Singapore Vascular Surgical Collaborative
(SingVasc), Vascupedia (European vascular education
platform), VASCUNET (collaboration of vascular reg-
istries), Australian and New Zealand Vascular Trials
Network (ANZVTN), Audible Bleeding (evidence-based
podcast, USA), British Society of Interventional Radi-
ology (BSIR), BSIR Trainees (BSIRT), International
Working Group on the Diabetic Foot (IWGDF), Euro-
pean Society of Vascular Surgery (ESVS), European
Vascular Surgeons in Training (EVST) and STAR-
Surg (UK-based student surgical research network).
They also thank S. Kandola and the Department of
Research and Development at University Hospitals
Coventry and Warwickshire NHS Trust (Coventry, UK),
I. Cruikshanks and T. Koller for Spanish and German
translations. These partner groups and colleagues have
enabled dissemination of the study and participation from
multiple nations worldwide, which has been invaluable in
the success of the COVER study to date.
The study has received financial grant support from
the VSGBI. The National Institute for Health Research
(NIHR) provided salary support for the co-chief investiga-
tors (reference NIHR000359).
Disclosure: The authors declare no conflict of interest.
References
1 COVIDSurg Collaborative. Global guidance for surgical
care during the COVID-19 pandemic. Br J Surg 2020; 107:
1097–1103.
2 The Vascular Society for Great Britain and Ireland.
COVID-19 Virus and Vascular Surgery; 2020. www
.vascularsociety.org.uk/professionals/news/113/covid19_
virus_and_vascular_surgery [accessed 8 May 2020].
3 Society for Vascular Surgery. COVID-19 Resources for
Members; 2020. https://vascular.org/news-advocacy/covid-
19-resources#Guidelines&Tools [accessed 10 May 2020].
4 American College of Surgeons. COVID-19 Guidelines for
Triage of Vascular Surgery Patients; 2020. https://www.facs
.org/covid-19/clinical-guidance/elective-case/vascular-
surgery [accessed 25 April 2020].
5 Mirza AK, Manunga J, Skeik N. Indirect casualties of
COVID-19: perspectives from an American vascular surgery
practice at a tertiary care centre. Br J Surg 2020; 107: e246.
6 The Vascular and Endovascular Research Network VERN
Executive Committee. The COvid-19 Vascular sERvice
(COVER) Study: an international Vascular and Endovascular
Research Network (VERN) Collaborative Study assessing
the provision, practice, and outcomes of vascular surgery
during the COVID-19 pandemic. Eur J Vasc Endovasc Surg
2020; 60: 156–157.
7 Gwilym BL, Saratzis A, Benson R, Forsythe R, Dovell G,
Dattani N et al. Study protocol for the Groin wound
Infection after Vascular Exposure (GIVE) audit and
multicentre cohort study. Int J Surg Protoc 2019; 16: 9–13.
8 Saratzis A, Jaspers NEM, Gwilym B, Thomas O, Tsui A,
Lefroy R et al.; Vascular and Endovascular Research
Network (VERN) Collaborators. Observational study of the
medical management of patients with peripheral artery
disease. Br J Surg 2019; 106: 1168–1177.
9 Saratzis A, Joshi S, Benson RA, Bosanquet D, Dattani N,
Batchelder A et al.; VERN collaborators. Acute kidney injury
(AKI) in aortic intervention: findings from the Midlands
Aortic Renal Injury (MARI) Cohort Study. Eur J Vasc
Endovasc Surg 2020; 59: 899–909.
10 Kelley K, Clark B, Brown V, Sitzia J. Good practice in the
conduct and reporting of survey research. Int J Qual Health
Care 2003; 15: 261–266.
11 Oliver-Williams C, Sweeting MJ, Jacomelli J, Summers L,
Stevenson A, Lees T et al. Safety of men with small and
medium abdominal aortic aneurysms under surveillance in
the NAAASP. Circulation 2019; 139: 1371–1380.
12 Public Health England. Abdominal Aortic Aneurysm Screening
Programme: Standards Data Report April 2017 to March 2018
(Gateway number: GW-77). PHE Publications: London,
2019.
13 Patel R, Sweeting MJ, Powell JT, Greenhalgh RM; EVAR
trial investigators. Endovascular versus open repair of
abdominal aortic aneurysm in 15-years’ follow-up of the UK
endovascular aneurysm repair trial 1 (EVAR trial 1): a
randomised controlled trial. Lancet 2016; 388: 2366–2374.
14 Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG,
Gillespie I et al.; BASIL trial participants. Bypass versus
Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An
intention-to-treat analysis of amputation-free and overall
survival in patients randomized to a bypass surgery-first or a
balloon angioplasty-first revascularization strategy. J Vasc
Surg 2010; 51(Suppl): 5S–17S.
15 COVIDSurg Collaborative. Elective surgery cancellations
due to the COVID-19 pandemic: global predictive modelling
to inform surgical recovery plans. Br J Surg 2020; https://doi
.org/10.1002/bjs.11746 (Epub ahead of print).
16 Mayol J, Fernández Pérez C. Elective surgery after the
pandemic: waves beyond the horizon. Br J Surg 2020;
https://doi.org/10.1002/bjs.11688 [Epub ahead of print].
17 Vogler SA, Lightner AL. Rethinking how we care for our
patients in a time of social distancing during the COVID-19
pandemic. Br J Surg 2020; 107: 937–939.
18 Søreide K, Hallet J, Matthews JB, Schnitzbauer AA, Line
PD, Lai PBS et al. Immediate and long-term impact of the
COVID-19 pandemic on delivery of surgical services. Br
J Surg 2020; https://doi.org/10.1002/bjs.11670 [Epub ahead
of print].
© 2020 The Authors. British Journal of Surgery published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2020; 107: 1396–1400
on behalf of BJS Society Ltd.
1400 The Vascular and Endovascular Research Network (VERN) COVER study collaborative
19 Jessop ZM, Dobbs TD, Ali SR, Combellack E, Clancy R,
Ibrahim N et al. Personal protective equipment (PPE) for
surgeons during COVID-19 pandemic: a systematic review
of availability, usage, and rationing. Br J Surg 2020; https://
doi.org/10.1002/bjs.11750 [Epub ahead of print].
20 Welsh Surgical Research Initiative (WSRI) Collaborative.
Surgery during the COVID-19 pandemic: operating room
suggestions from an international Delphi process. Br J Surg
2020; https://doi.org/10.1002/bjs.11747 [Epub ahead of
print].
21 Mowbray NG, Ansell J, Horwood J, Cornish J, Rizkallah P,
Parker A et al. Safe management of surgical smoke in the age
of COVID-19. Br J Surg 2020; https://doi.org/10.1002/bjs
.11679 [Epub ahead of print].
Supporting information











































© 2020 The Authors. British Journal of Surgery published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2020; 107: 1396–1400
on behalf of BJS Society Ltd.
